The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV

Table 1

Comparison of the clinical indexes between stage IV and non-stage IV groups.

Indexes	Stage IV group	Non-stage IV group	value
Gender			0.085
Male	63	291
Female	36	110
Age (yr)	61.29 ± 12.92	62.01 ± 11.24	0.802
AFP (ng/mL)	8.06 ± 29.37	3.5 ± 6.95	0.006
CEA (ng/mL)	130.50 ± 784.63	6.66 ± 36.10	0.002
CA125 (U/mL)	42.45 ± 55.44	10.36 ± 8.33	≤0.001
CA199 (U/mL)	522.09 ± 2187.79	43.35 ± 190.26	≤0.001
CA724 (U/mL)	372.37 ± 3129.16	7.21 ± 42.39	0.022
CA242 (U/mL)	473.32 ± 1925	31.30 ± 208.94	≤0.001
TT (s)	17.83 ± 1.57	18.38 ± 1.45	0.001
PT (s)	12.23 ± 0.88	11.91 ± 1.21	0.015
APTT (s)	29.77 ± 4.20	28.37 ± 4.00	0.002
PLT (10^9/L)	233.19 ± 99.08	208.22 ± 69.68	0.004
WBC (10^9/L)	6.02 ± 1.83	5.5 ± 1.52	0.005
CRP (mg/L)	12.41 ± 18.75	4.38 ± 4.78	≤0.001
NC (10^9/L)	3.9 ± 1.58	3.24 ± 1.15	≤0.001
LC (10^9/L)	1.49 ± 0.56	1.73 ± 0.62	0.001
NLR	3.10 ± 1.99	2.07 ± 1.05	≤0.001
HB (g/L)	113.45 ± 25.53	124.48 ± 25.53	≤0.001
ALB (g/L)	36.80 ± 4.05	39.18 ± 15.33	0.129
ALT (U/L)	21.30 ± 28.90	18.19 ± 10.31	0.08
AST (U/L)	24.89 ± 27.71	19.28 ± 6.98	≤0.001
TB (μmol/L)	10.63 ± 4.94	11.27 ± 5.45	0.289
DB (μmol/L)	3.67 ± 1.97	3.55 ± 1.86	0.586
Ascites			≤0.001
Yes	47	0
No	52	401